5% Lidocaine HCl and 7 — Class II drug recall D-66201-001
Terminated recall by Hospira Inc., reported 2013-10-09, distributed nationwide. Presence of Particulate Matter; report of visible particulates in the glass ampule
| Recall number | D-66201-001 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira Inc., Lake Forest, IL, United States |
| Recall initiated | 2013-08-29 |
| Classified | 2013-10-02 |
| Reported by FDA | 2013-10-09 |
| Terminated | 2014-11-10 |
| Distributed | Nationwide (US) |
| Quantity | 86,400 ampuls |
| Reason classes | foreign material, specification failure |
| NDC | 00409-4712-01 |
| Lot numbers | 23-227-DK |
Product
5% Lidocaine HCl and 7.5% Dextrose Injection, USP, 2 mL Single Dose Ampuls, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4712-01
Reason for recall
Presence of Particulate Matter; report of visible particulates in the glass ampule
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-66201-001. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.